TAKEDA
LIVE

Serial Number

98377551

Owner

TAKEDA PHARMACEUTICAL COMPANY LIMITED

Attorney

Karl M. Zielaznicki, Esq.

First Use Date

Jan 1, 2020

Filing Date

Jan 26, 2024

Add to watchlist:

No watchlists yet
View on USPTO

TAKEDA Trademark

Serial Number: 98377551 • Registration: 7608206

TAKEDA is a trademark filed by TAKEDA PHARMACEUTICAL COMPANY LIMITED on January 26, 2024. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

TAKEDA PHARMACEUTICAL COMPANY LIMITED (367 trademarks)

1-1, DOSHOMACHI 4-CHOME
CHUO-KU, OSAKA , JP

Entity Type: 03

Trademark Details

Filing Date

January 26, 2024

Registration Date

December 17, 2024

First Use Anywhere

January 1, 2020

First Use in Commerce

January 1, 2020

Published for Opposition

October 15, 2024

Goods & Services

Medical devices used for administering pharmaceutical preparations for use in treating or diagnosing, disorders, diseases, and rare diseases in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders; medical devices for reconstituting pharmaceutical preparations for use in treating or diagnosing disorders, diseases, and rare diseases in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders; medical devices for reconstituting and administering pharmaceutical preparations. for use in treating or diagnosing, disorders, diseases, and rare diseases in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 17, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 15, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 15, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 25, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 6, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 3, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 3, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 21, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 21, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 21, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 21, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 31, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 31, 2024 NWOS
NEW APPLICATION ENTERED
Jan 26, 2024 NWAP